Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 3:58 a.m.

    📋 Turning Point Therapeutics, Inc. (TPTX) - Business Combination

    Filing Date: 2022-06-03

    Accepted: 2022-06-03 17:15:57

    Event Type: Business Combination

    Event Details:

    Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) Announces Business Combination Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) has entered into a strategic transaction. Transaction Details:
    • Deal Value: $138 million

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes

    Structured Data:

    • Company Name: Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY))
    • CIK: 0001595893
    • Ticker Symbol: TPTX
    • Period End Date: 2022-06-02
    • Document Type: 8-K

Search

News categories